BusinessPeregrine to Report Financial Results for Second Quarter of Fiscal Year 2017 After Market Close on December 12, 2016By Nasdaq OMXDec 5, 2016, 9:05 PM UTC
BusinessDriving Out Pediatric Cancer: Hyundai Hope On Wheels® Awards $7.5 Million in Grants to Fight Pediatric Cancer and Gives Hope a HandBy Nasdaq OMXDec 5, 2016, 8:28 PM UTC
BusinessPetLife Pharmaceuticals Updates Shareholders on the Company Progress with Vitalzul™ Studies and Additional Product OfferingsBy Nasdaq OMXDec 1, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Updates Shareholders on the Company Progress with Vitalzul™ Studies and Additional Product OfferingsBy Nasdaq OMXDec 1, 2016, 1:01 PM UTC
BusinessKura Oncology Presents Preclinical Data on KO-947 and Menin-MLL Inhibitor Program at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsBy Nasdaq OMXDec 1, 2016, 12:30 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessKura Oncology to Present Preclinical Data on Pipeline Programs at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsBy Nasdaq OMXNov 15, 2016, 12:30 PM UTC
